Cutaquig ® Is Well Tolerated in Immunodeficient Patients Who Did Not Tolerate Other Subcutaneous Immunoglobulin Products.
Sydney BrownleeCrystal AllenMohammed F Kana'anDonald William CameronJuthaporn CowanPublished in: Hematology reports (2022)
may be used as an alternative treatment option for patients who did not tolerate 20% SCIG products.
Keyphrases